NCT05800574 Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer Status RECRUITING Phase PHASE2
NCT05800054 Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer Status RECRUITING Phase NA
NCT05800015 A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05799469 Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05798819 A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT05791097 Study of Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Platinum-based Doublet Chemotherapy as First-line Treatment for Participants With Locally Advanced or Metastatic NSCLC. Status WITHDRAWN Phase PHASE3
NCT05789082 A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation Status RECRUITING Phase PHASE1/PHASE2
NCT05775159 Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer Status RECRUITING Phase PHASE2
NCT05766605 Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial Status RECRUITING Phase PHASE3
NCT05765825 Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05753306 Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study Status RECRUITING Phase PHASE2
NCT05751187 Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05738161 Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma Status WITHDRAWN Phase PHASE1
NCT05730777 Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics Status UNKNOWN Phase PHASE4
NCT05726370 Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC Status RECRUITING Phase PHASE2
NCT05722015 A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05721755 Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05717790 Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma Status RECRUITING Phase NA
NCT05715840 Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1) Status NOT_YET_RECRUITING Phase PHASE3
NCT05712356 A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE2